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¿CUÁLES SON LOS MÉTODOS MÁS EFICACES
DE VALORACIÓN DEL ESTADO NUTRICIONAL
EN PACIENTES AMBULATORIOS CON
CÁNCER GÁSTRICO Y COLORRECTAL?
Resumen
Objetivo: Evaluar los métodos para la identificación del
riesgo nutricional y del estado nutricional en pacientes
ambulatorios con cáncer colorrectal (CCR) y cáncer
gástrico (CG) y comparar los resultados con los obtenidos
por los pacientes ya tratados por estos cánceres. 
Métodos: Se realizó un estudio transversal en 137
pacientes: el grupo 1 (n = 75) comprendía pacientes con
CG o CCR y el grupo 2 (n = 62) comprendía pacientes tras
el tratamiento de CG o CCR en seguimiento y que
estaban libres de tumor por un periodo mayor de 3 meses.
Se evaluó el estado nutricional de estos pacientes usando
métodos objetivos [índice de masa corporal (IMC), el
ángulo de fase y la albúmina sérica]; herramientas de
cribado nutricional [Malnutrition Universal Screening
Tool (MUST), Malnutrition Screening Tool (MST),
Nutritional Risk Index (NRI)] y una evaluación subjetiva
[Evaluación Global Subjetiva Generada por el Paciente
(EGS-GP)]. La sensibilidad y especificidad de cada
método se calcularon con relación a la EGS-GP, que se
empleó como prueba de referencia. 
Resultados: 137 pacientes participaron en el estudio.
Los pacientes con cáncer en estadio IV fueron más
frecuentes en el grupo 1. No hubo diferencias en el IMC
entre los grupos (p = 0,67). El análisis de la asociación
entre los métodos de evaluación nutricional y la EGS-
GP mostró que las herramientas de cribado nutricional
proporcionaban resultados más significativos (p < 0,05)
que los métodos objetivos en ambos grupos. La EGS-GP
detectó la mayor proporción de pacientes desnutridos en
el grupo 1. Las herramientas de cribado nutricional
MUST, NRI y MST eran más sensibles que los métodos
objetivos. La medición del ángulo de fase fue el método
objetivo más sensible en el grupo 1. 
Conclusión: Las herramientas de cribado nutricional
mostraron la mejor asociación con la EGS-GP y también
fueron más sensibles que los métodos objetivos. Los resul-
tados sugieren el uso de la combinación de MUST y EGS-
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Abstract
Objective: To evaluate methods for the identification of
nutrition risk and nutritional status in outpatients with
colorectal (CRC) and gastric cancer (GC), and to
compare the results to those obtained for patients already
treated for these cancers. 
Methods: A cross-sectional study was conducted on 137
patients: group 1 (n = 75) consisting of patients with GC or
CRC, and group 2 (n = 62) consisting of patients after treat-
ment of GC or CRC under follow up, who were tumor free
for a period longer than 3 months. Nutritional status was
assessed in these patients using objective methods [body
mass index (BMI), phase angle, serum albumin]; nutri-
tional screening tools [Malnutrition Universal Screening
Tool (MUST), Malnutrition Screening Tool (MST), Nutri-
tional Risk Index (NRI)], and subjective assessment
[Patient-Generated Subjective Global Assessment (PG-
SGA)]. The sensitivity and specificity of each method was
calculated in relation to the PG-SGA used as gold standard. 
Results: One hundred thirty seven patients participated
in the study. Stage IV cancer patients were more common
in group 1. There was no difference in BMI between groups
(p = 0.67). Analysis of the association between methods of
assessing nutritional status and PG-SGA showed that the
nutritional screening tools provided more significant
results (p < 0.05) than the objective methods in the two
groups. PG-SGA detected the highest proportion of under-
nourished patients in group 1. The nutritional screening
tools MUST, NRI and MST were more sensitive than the
objective methods. Phase angle measurement was the most
sensitive objective method in group 1. 
Conclusion: The nutritional screening tools showed the
best association with PG-SGA and were also more sensi-
tive than the objective methods. The results suggest the
combination of MUST and PG-SGA for patients with
cancer before and after treatment.
(Nutr Hosp. 2013;28:585-591)
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BMI: Body mass index.
MUST: Malnutrition Universal Screening Tool.
MST: Malnutrition Screening Tool.
NRI: Nutritional Risk Index.
PG-SGA: Patient-Generated Subjective Global
Assessment.
SGA: Subjective Global Assessment.
PhA: Phase angle.
Introduction
Colorectal cancer (CRC) and gastric cancer (GC) are
the most common cancers in the world.1,2 Gastroin-
testinal tract tumors can cause obstruction and impair
nutrient absorption, events that result in weight loss.3
These patients therefore require adequate monitoring
of nutritional status. Several methods are used for the
assessment of nutritional status in cancer patients, but
no gold standard exists since these methods are not
specific for this group of patients and are influenced by
factors that are independent of nutritional status.5
Within this context, nutritional status of cancer patients
is evaluated using objective methods such as anthropo-
metric and biochemical parameters, nutritional indices
and body composition measures, nutritional screening
tools, and subjective methods.6,7
The body mass index (BMI) is commonly used in
epidemiological studies and clinical practice because of
its simplicity, low cost, and satisfactory association with
fat mass, morbidity and mortality, but shows low sensi-
tivity in the diagnosis of undernutrition.8-10 Biochemical
parameters such as serum albumin can also be used for
nutritional assessment. However, changes in these para-
meters may occur due to the underlying disease and may
not reliably reflect nutritional status.6
Phase angle is a parameter used in electrical bioim-
pedance analysis. A low phase angle suggests cell
death or a decline in cell integrity. This parameter has
been validated in several diseases, including cancer.11-13
The Malnutrition Universal Screening Tool (MUST)
was developed for the detection of protein-calorie
malnutrition and the identification of malnutrition risk
using evidence-based standards.14 This instrument has
been validated as a nutritional screening tool in cancer
patients undergoing radiotherapy.15 The Malnutrition
Screening Tool (MST) is a quick and simple nutritional
screening tool based on weight loss and appetite
changes, which has been validated for use in outpa-
tients with cancer undergoing radiotherapy and inpa-
tients.16,17 The Nutritional Risk Index (NRI) gained
popularity because it differs from other assessment
instruments by using objective parameters. This tool
has been used for the evaluation of patients with
different conditions and clinical outcomes and to
monitor the impact of nutritional interventions. It was
first used in hospitalized patients, but was later
successfully applied to other groups of patients.18-20
The Patient-Generated Subjective Global Assess-
ment (PG-SGA) tool21 is an adaptation of the Subjec-
tive Global Assessment (SGA),22 recommended by the
Oncology Nutrition Dietetic Practice Group of the
American Dietetic Association as standard for the
nutritional assessment of cancer patients.23,24 It empha-
sizes symptoms commonly seen during the treatment
of cancer and includes a physical examination for the
subjective assessment of nutritional status.
In view of the highly prevalent nutritional depletion
and importance of assessing nutritional status in cancer
patients, the objective of the present study was to eval-
uate nutritional screening tools and subjective and
objective methods for the identification of nutrition
risk and nutritional status in patients with CRC and
GC, and to compare the results to those obtained for
patients treated for these cancers. 
Patients and methods
Subjects
A cross-sectional study involving outpatients treated
by the Oncology Group of the Gastroenterology Divi-
sion, Federal University of Sao Paulo, was conducted
between July 2010 and December 2011. Two different
groups of patients were studied. The group 1 consisted
of patients with CRC or GC with active disease under-
going or not chemotherapy and the group 2 consisted of
patients under follow-up who had been treated for CRC
or GC and who were tumor free for a period longer than
3 months.
The study was approved by the local Ethics
Committee (Protocol 0826/10) and all patients signed
an informed consent form. 
Data collection
Data on gender, age, treatment and tumor were
obtained from the medical records. The methods used
in the study were applied on a single occasion, i.e., the
patient was approached only once to assess nutritional
variables and to collect blood for the determination of
serum proteins.
Objective methods for the assessment 
of nutritional status
Weight (kg) and height (cm) were measured for the
determination of BMI. The subjects were classified
according to the World Health Organization criteria25
as undernourished (BMI < 18.5 kg/m2) or well nour-
ished (BMI ≥ 18.5 kg/m2).
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The phase angle was calculated as the ratio between
resistance (R) and reactance (Xc) determined with a
Biodynamics 450® bioimpedance analyzer using a
standard technique. R and Xc were measured directly
in Ohms (Ω) at a single frequency of 50 kHz and 800
µA. The phase angle (PhA) was calculated using the
following equation: PhA = arctan (Xc/R) × (180/3.14).
The measurements were obtained early in the morning
after a fast of at least 4 hours. All procedures and
control for other variables affecting the validity, repro-
ducibility and precision of the measurements were
performed according to the National Institutes of
Health guidelines.13
Serum albumin levels were measured by the
bromocresol purple method (Biosystems®). The cut-off
value was 3.5 mg/dL.26
Nutritional screening tools for the assessment 
of nutritional status
MUST uses three independent criteria for determi-
nation of the overall risk of undernutrition: BMI,
percentage of weight loss over the previous 3-6
months, and if there has been or is likely to be no nutri-
tional intake for > 5 days.14,15 The MST consists of two
questions related to recent unintentional weight loss
and low food intake because of decreased appetite.
This tool provides a score between 0-5, with a score ≥ 2
indicating a risk of undernutrition.16 The NRI was
derived from serum albumin concentration and the
ratio of actual to usual weight (1.519 × serum albumin,
g/dL) + [41.7 × actual weight (kg)/ideal body weight
(kg)]. Four categories of nutrition-related risk were
defined: high risk, moderate risk, low risk, or no nutri-
tional risk.18,19
Subjective method for the assessment 
of nutritional status
The validated Portuguese version of the scored PG-
SGA was used to assess nutritional status.27 PG-SGA
consists of two sections: (1) weight history, food
intake, nutrition impact symptoms and functional
capacity; (2) diagnosis, disease stage, age, components
of metabolic demand (sepsis, neutropenic or tumour
fever, corticosteroids) and physical examination.
Subjective analysis classified the patients into three
categories: (A) well-nourished, (B) moderately under-
nourished or suspected of being undernourished, and
(C) severely undernourished. For the present study,
and for between methods comparisons, two categories
of the PG-SGA results were created: well nourished
and undernourished if moderately or severely under-
nourished, to enable comparisons with other methods.15
The PG-SGA had been considered the gold standard
to determine the sensitivity and specificity of the others
methods used to evaluate the nutritional status. This
tool had been validated for assessing nutritional status
of patients with cancer21 and is the most complete and
patient-related cancer instrument used in our study. 
Statistical analysis
For descriptive statistics, quantitative variables are
expressed as the mean and standard deviation and cate-
gorical (qualitative) variables as absolute and relative
frequencies. The chi-squared test was used for compar-
ison between groups and the Student t-test to compare
continuous parametric variables. For the evaluation of
phase angle, a cut-off value was established for the
population studied because of the lack of specific
values for cancer patients. The phase angle was divided
by the distribution measured according to the propor-
tion of observed frequencies. The data were separated
into quartiles and values of the first quartile were
defined as predictors of undernutrition. 
Sensitivity and specificity of the methods used to
assess nutritional status were calculated considering
PG-SGA as the gold standard. The sensitivity test
determines the proportion of true positives by the
analysis of patients who are indeed undernourished,
according to the PG-SGA. It is the proportion of indi-
viduals who have a positive result (undernourished,)
when compared to the standard method of analysis and
the total undernourished, by the PG-SGA. Specificity,
in contrast, verified the ability of the methods to iden-
tify true negatives, analyzing the absence of undernu-
trition according to the standard method. 
The test sensitivity was the proportion between the
number of patients with BMI < 18.5 kg/m2, phase angle
values in the first quartile, cut-off value for albumin
< 3.5 mg/dL and “risk of undernutrition”, by the
screening tool MUST, MST and NRI and undernutri-
tion diagnosed by PG-SGA. On the other hand the
specificity refers to the proportion of patients without
nutritional deficiency by the method studied compared
to the well nourished by PG-SGA.
The chi-squared test was used to evaluate the degree
of association between PG-SGA and the other
methods. Statistical analysis was performed using the
SPSS 16.0 program (2008, SPSS, Inc., Chicago, IL). A
two-sided p-value < 0.05 was considered to indicate
significance.
Results
A total of 137 patients were eligible for the study (75
in group 1 and 62 in group 2) (table I). Advanced stage
disease was more common on the group 1. In group 1,
40% of the patient had not received any treatment, 60%
patients were receiving chemotherapy and of those
54.7% underwent surgery. Group 2 consisted of
patients under follow up; 48.38% had received
chemotherapy and all of them underwent surgical
Methods for assessment of nutritional
status in outpatients with gastric and
colorectal cancer?
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resection of the tumor. Comparing groups 1 and 2, the
percentage of weight loss was 3.42 ± 4.86 versus 1.20 ±
2.30 in one month and 10.79 ± 9.73 versus 4.99 ± 8.88
in 6 months. The prevalence of moderate/severe under-
nutrition determined by the PG-SGA was 66.6% in
group 1. According to BMI, only 6.7% of the patients
were undernourished. Despite the nutritional assess-
ment the BMI was the only method that revealed no
significant difference (table II). 
Significant associations (p < 0.05) were observed
between the PG-SGA, considered a gold standard and
most of the objective methods and nutritional
screening tools used. The association between PG-
SGA and the objective methods BMI in group 1 or
albumin in group 2 were not significant (table III).
Analysis of the sensitivity and specificity of the
methods used to assess nutritional status, calculated in
relation to the PG-SGA showed low sensitivity, but
high specificity, of the objective methods in the two
groups. Phase angle measurement was the most sensi-
tive method in group 1 (44%). MUST was the most
sensitive nutritional screening tool (72% in group 1 and
84% in group 2) (table IV).
A high specificity of BMI (100% for both groups)
had been observed because all the patients well nour-
ished by this index had not undernutrition by the PG-
SGA. Similarly most of the patients with normal serum
levels of albumin were also well nourished by the PG-
SGA (specificity of 92% for group 1 and 93.8% for
group 2) (table IV). 
Discussion
Patients with GC and CRC were included in this
study because of the high prevalence of these cancers
and of difficulties in the early identification of nutri-
tional status since BMI can underestimate the current
nutritional status of these patients.8 Colorectal cancer
was more prevalent than GC in the two groups, in
agreement with Global Cancer Statistics data.1 There
were no patients with stage IV cancer in group 2
because the cure rate is low in advanced disease.1,2
All nutritional assessment methods tested revealed a
significant difference between the two groups, except
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Table I
Characteristics of the patients in both groups
Parameters Group 1 Group 2 p
n (%) n (%)
Age
(yr + SD) 60.2 + 12.2 61-3 + 11.6 0.621
Gender
Male 36 (48) 28 (45.2) 0.740Female 39 (52) 34 (54.8)
Localization
Colorectal 64 (85.3) 52 (83.9) 0.813Gastric 11 (14.7) 10 (16.1)
Stage
I 3 (4) 11 (17.7)
II 10 (13.3) 28 (45.2)
< 0.001III 15 (20) 23 (37.1)
IV 47 (62.7) 0 (0)
Table III
Association between the PG-SGA and the nutritional
screening or objectives methods in both groups
Method Group p*
BMI G1 < 0.102G2 < 0.005
Phase angle G1 < 0.041G2 < 0.006
Albumin G1 < 0.032G2 < 0.276
MUST G1 < 0.086G2 < 0.001
MST G1 < 0.003G2 < 0.001
NR1 G1 < 0.008G2 < 0.005
Table II
Nutritional assessment results in both groups
Parameters Group 1 Group 2 p
n (%) n (%)
BMI (kg/m2)
< 18.5 (undernourished) 5 (6.7) 2 (3.2)
18.5-24.9 (normal) 41 (54.7) 29 (46.8) 0.679
25-29.9 (overweight) 22 (29.3) 22 (35.5)
≥ 30.0 (obese) 7 (9.3) 9 (14.5)
Phase angle
< QI 27 (36.0) 9 (14.5) 0.008> QI 48 (64.0) 53 (85.5)
Albumin
> 3.5 mg/dL 58 (77.3) 57 (91.9) 0.020< 3.5 mg/dL 17 (22.7) 5 (8.1)
MUST
Low risk of undernutrition 26 (34.7) 38 (61.3)
Moderate risk of undernutrition 8 (10.7) 11 (7.7) < 0.001
High risk of undernutrition 41 (54.7) 13 (21.0)
MST
Nutritional risk 30 (40.0) 12 (19.4) 0.015No nutritional risk 45 (60.0) 50 (80.6)
NRI
No nutritional risk (> 100) 32 (42.7) 47 (75.8)
Low risk (97.5-100) 8 (10.7) 3 (4.8) 0.002
Moderate risk (83.5-97.5) 7 (9.3) 2 (3.2)
High nutritional risk (< 83.5) 28 (37.3) 10 (26.1)
PG-SGA
Well nourished 25 (33.3) 49 (79)
Moderately undernourished 40 (53.3) 11 (27.7) < 0.001
Severetely undernourished 10 (13.3) 2 (3.2)
QI: First quartil.
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for BMI. This index had already been described as
having lower sensitivity in the diagnosis of undernutri-
tion.8-10
The risk of undernutrition were higher in patients
with cancer (group 1) than in patients under follow-up
(group 2) due to the disease stage and chemotherapy
treatment. One consistent explanation for this finding
is the fact that the presence of the tumor is more likely
to cause nutrient depletion in the former.5
Among the 27 (26.3%) patients with a phase angle
< first quartile (cut-off: 5.1), 22 (81.48%) were also
classified as undernourished by the PG-SGA. In a
study evaluating the relationship between phase angle
and SGA in patients with advanced CRC, Gupta et al.28
obtained a cut-off similar to that of the present study
(5.2), which showed 51.7% sensitivity and 79.5%
specificity in detecting undernutrition. The authors
concluded that PhA can be used as an indicator of nutri-
tional status. In the present study, phase angle was
found to be the most sensitive objective method for the
diagnosis of undernutrition. It is therefore proposed
that PhA can complement other nutritional data,
predicting functionality, quality of life and prognosis in
patients with cancer.29
Hypoalbuminemia occurs due to a systemic inflam-
matory response and nutrient depletion caused by the
tumor.30 This condition is therefore more common
among patients with metastases. In the present study,
62.7% of the patients had metastatic cancer and
hypoalbuminemia was observed in only 34.0% of
them. In contrast, albumin was identified as an indi-
cator of nutritional risk in a study involving patients
with metastatic cancer.6 In view of these divergent
results, there is no consensus regarding the validity of
serum albumin concentration as a parameter for the
diagnosis of undernutrition.
In a recent validation of MUST involving 450 cancer
patients under radiotherapy, including CRC patients,15
the percentage of patients at high nutritional risk (17%)
was low. In the present study, MUST showed the
highest sensitivity (72%) in the detection of nutritional
risk in patients with cancer, but its specificity was low
(48.9%). Boléo-Tomé et al.15 also reported high sensi-
tivity (80%) and specificity (89%) of this tool in rela-
tion to the PG-SGA. The percentage of weight loss,
which is an important factor in the MUST question-
naire, may have been responsible for the differences
between studies.15,31 The high prevalence of patients
with increased nutritional risk found in the present
investigation may be a consequence of the higher
percentage of weight loss. Another factor that may
have contributed in difference the studies were that
Boléo-Tomé et al15 evaluated predominantly patients
with breast and prostate cancers, which are associated
with lower weight loss compared to patients the present
study.
Among the nutritional screening tools, the MST
showed the lowest sensitivity and highest specificity.
Higher sensitivity and specificity have been reported
by Isering et al.32 who compared the MST and PG-SGA
in oncology outpatients. This lower sensitivity
observed in the present study might be due to the fact
that the patients had a history of weight loss, but their
current weight recovery was not computed in the stan-
dardized MST score. 
Although the NRI is frequently used in hospital
patients,18,19 in the present study this tool showed
important sensitivity in the detection of undernutrition
in outpatients. In a study on patients with GC who
underwent curative gastrectomy, the NRI was consid-
ered a predictor of postoperative complications.33
A high prevalence of undernutrition was detected by
the PG-SGA, with 66.6% of the patients in group 1
being classified as moderately or severely undernour-
ished. Another study including CRC patients under-
going chemotherapy, with a similar percentage of stage
IV cancer, reported a lower frequency of patients with
moderate or severe undernutrition (42.4%).34 This
difference might be due to the inclusion of patients
with GC in the present study, who usually present a
higher risk of undernutrition.35
We chose to determine the sensitivity and speci-
ficity of nutritional assessment methods in relation to
the PG-SGA since the effectiveness of the latter has
been demonstrated in several studies, specifically in
cancer patients.21,24,31 The PG-SGA was able to iden-
tify patients at nutritional risk and can therefore be
considered a nutritional screening method.27 Bauer et
al.24 also reported a higher sensitivity and specificity
of the PG-SGA compared to the standard SGA in
hospitalized patients with cancer. Significant and
Methods for assessment of nutritional
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similar associations between the PG-SGA and most
nutritional screening variables were observed in the
two groups. However, these associations were lower
for the objective methods. The predominance of
significant associations between the nutritional
screening tools and PG-SGA may be due to the pre-
established relationship between these methods.
These results suggest the maintenance of nutritional
risk assessment by nutritional screening tools, and if
the presence of a nutritional risk is confirmed, the
patient should undergo complete nutritional assess-
ment using the PG-SGA. 
This study has some limitations such as the small
number of patients with GC. Furthermore, the lower
sensitivity and specificity of nutritional assessment
observed in this study when compared to other reports
may be due to the fact that the subjects were outpatients
and to the predominance of patients with CRC in good
general health. However, this is the first study
comparing nutritional assessment methods between
patients with cancer and patients with a history of
cancer under follow-up.
In conclusion, the nutritional screening tools tested
showed higher sensitivity and lower specificity than
the objective methods in the assessment of nutritional
status when the PG-SGA was used as gold standard.
We suggest the combination of the nutritional
screening tool MUST and PG-SGA for the assessment
of nutritional status. Although the percentage of
patients at nutritional risk or with moderate/severe
undernutrition is high among cancer patients, these
alterations are also observed in the group of already
treated patients, a fact highlighting the need for
assessing nutritional status in both groups. 
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